← FDA Drug Approvals (Drugs@FDA)

COSELA

NDA · New Drug Application · Sponsor: PHARMACOSMOS · Approved 2021-02-12

Drug application

FDA Application #

NDA214200

Application type

New Drug Application

Brand name

COSELA

Generic name

TRILACICLIB

Active ingredients

TRILACICLIB DIHYDROCHLORIDE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

PHARMACOSMOS

Manufacturer

G1 Therapeutics, Inc.

First approval

2021-02-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown